BioPhausia (OTC products) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

BioPhausia (OTC products) General Information

Description

A portfolio of OTC products comprising of novalucol, novalucid, c-vimin and resulax brands.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Commercial Products
Acquirer
Primary Office
  • Blasieholmsgatan 2
  • 111 48 Stockholm
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioPhausia (OTC products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioPhausia (OTC products)‘s full profile, request access.

Request a free trial

BioPhausia (OTC products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioPhausia (OTC products)‘s full profile, request access.

Request a free trial